Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
Crossref DOI link: https://doi.org/10.1208/s12248-015-9846-1
Published Online: 2015-11-23
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mensing, Sven
Polepally, Akshanth R.
König, Denise
Khatri, Amit
Liu, Wei
Podsadecki, Thomas J.
Awni, Walid M.
Menon, Rajeev M.
Dutta, Sandeep
Text and Data Mining valid from 2015-11-23